Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …

Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …

Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …

Background As large-scale immunization programs against COVID-19 proceed around the
world, safety signals will emerge that need rapid evaluation. We report population-based, age…

OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …

Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …

Objective Patients with autoimmune diseases were advised to shield to avoid coronavirus
disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-…

Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …

Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments,
and health outcomes among children/adolescents diagnosed or hospitalized with COVID-…